ASOP Canada Urges Health Canada to Protect Canadian Drug Supply in Wake of U.S. Drug Importation Legislation

ASOP Global

HDA Statement on the President’s Drug Affordability Executive Orders
Healthcare Distribution Alliance (HDA)

ASOP Canada Urges Health Canada to Protect Canadian Drug Supply in Wake of U.S. Drug Importation Legislation

ASOP Canada Incite Santé Canada À Protéger L’Approvisionnement Des Médicaments Au Canada Avec La Récente Adoption De Lois D’Importations De Médicaments Aux États-Unis

ASOP Canada

Joint Statement in Opposition to U.S. Federal Legislation Authorizing Importation of Prescription Drugs from Canada
Canadian Pharmacists Association (CPhA) and the American Pharmacists Association (APhA)

NABP Statement on Prescription Drug Importation Proposals
National Association of Boards of Pharmacy

ASOP Canada Statement on New U.S. Drug Importation Proposals
La Déclaration d’ASOP Canada sur Les Nouvelles Propositions d’Importation de Médicaments Américaine
ASOP Canada

National Sheriffs’ Association Statement Opposing Legislation On Prescription Drug Importation
Jonathan Thompson
Executive Director and CEO
National Sheriffs’ Association

National Consumers League Statement on FDA Importation Work Group
Sally Greenberg
Executive Director
National Consumers League

HDA Statement on FDA Work Group to Examine Prescription Drug Importation
John M. Gray
President and CEO
Healthcare Distribution Alliance

Partnership For Safe Medicines Statement On FDA Working Group On Drug Importation
Shabbir Imber Safdar
Executive Director
Partnership for Safe Medicines

AAM Statement on Importation Task Force
Association for Accessible Medicines

Drug Importation From Canada Increases Patient Risk With No Guarantee of Lower Prices
Ronald T. Piervincenzi, PH.D.
CEO
U.S. Pharmacopeial Convention